![](/img/cover-not-exists.png)
Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD
Socié, Gérard, Milpied, Noel, Yakoub-Agha, Ibrahim, Bay, Jacques-Olivier, Fürst, Sabine, Bilger, Karin, Suarez, Felipe, Michallet, Mauricette, Lewalle, Philippe, Liens, David, Mathis, Catherine, GuVolume:
3
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2018028282
Date:
January, 2019
File:
PDF, 667 KB
2019